George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Huntsworth Plc - AMENDMENT

21 Apr 2020 11:53

RNS Number : 3649K
BNP Paribas London
21 April 2020
 

FORM 8.3 AMENDMENT

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

This form is an Amendment to RNS 2118K that was released yesterday, 20/04/2020. Changes have been made to Section 2a and Section 3b.

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BNP PARIBAS GROUP SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Huntsworth PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORDINARY SHARES (ISIN: GB00B0CRWK29)

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,148,056

 

1.66

(2) Cash-settled derivatives:

 

6,281,828

 

1.70

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

 

6,148,056

 

1.66

6,281,828

 

1.70

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GB00B0CRWK29

Purchase

2,000,000

GBP 1.0755

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GB00B0CRWK29

CFD

Increasing a short position

2,000,000

GBP 1.0755

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

21 April 2020

Contact name:

Alok Prinja

Telephone number:

0207 595 9695

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETBFLFLBZLEBBL
Date   Source Headline
19th Dec 20193:51 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSTrading Update
6th Dec 20191:59 pmRNSHoldings in Company
2nd Dec 201910:54 amRNSTotal Voting Rights
11th Nov 201910:31 amRNSHolding(s) in Company
6th Nov 20199:11 amRNSDirector Declaration
5th Nov 20195:31 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSAdditional Listing
1st Nov 20197:00 amRNSTotal Voting Rights and Capital
30th Oct 201910:22 amRNSDirector Declaration
15th Oct 20197:00 amRNSAdditional Listing
3rd Oct 201911:59 amRNSScrip Dividend Alternative
1st Oct 20197:00 amRNSBoard Changes
30th Sep 201911:35 amRNSNotification of Major Holdings
4th Sep 201912:07 pmRNSSecond Price Monitoring Extn
4th Sep 201912:02 pmRNSPrice Monitoring Extension
2nd Sep 20197:00 amRNSTotal Voting Rights and Capital
15th Aug 20197:00 amRNSAdditional Listing
8th Aug 201912:02 pmRNSPrice Monitoring Extension
1st Aug 201911:52 amRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSTotal Voting Rights
31st Jul 20194:41 pmRNSSecond Price Monitoring Extn
31st Jul 20194:35 pmRNSPrice Monitoring Extension
29th Jul 201912:08 pmRNSSecond Price Monitoring Extn
29th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 20194:41 pmRNSSecond Price Monitoring Extn
24th Jul 20194:35 pmRNSPrice Monitoring Extension
23rd Jul 20197:00 amRNSInterim Results
22nd Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 201910:00 amRNSDirector Declaration & Directorate Change
8th Jul 201911:43 amRNSStandard form for notification of major holdings
3rd Jul 20197:00 amRNSAdditional Listing
1st Jul 20197:00 amRNSTotal Voting Rights and Capital
13th Jun 20194:12 pmRNSDirector/PDMR Shareholding
12th Jun 201910:00 amRNSAdditional Listing
3rd Jun 20198:59 amRNSTotal Voting Rights
31st May 201910:28 amRNSFinal Dividend for 2018
29th May 20194:40 pmRNSSecond Price Monitoring Extn
29th May 20194:35 pmRNSPrice Monitoring Extension
24th May 20193:53 pmRNSNotification of Major Shareholdings
23rd May 20199:56 amRNSDirector/PDMR Shareholding
23rd May 20199:51 amRNSDirector/PDMR Shareholding
21st May 20197:01 amRNSCC and Kyne acquisitions announcement
9th May 20192:23 pmRNSResults of Annual General Meeting
9th May 20197:00 amRNSTrading Update
12th Apr 20197:00 amRNSCapital Markets Day
11th Apr 20194:40 pmRNSSecond Price Monitoring Extn
11th Apr 20194:35 pmRNSPrice Monitoring Extension
5th Apr 20195:57 pmRNSNotice of AGM
22nd Mar 20194:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.